StockData
Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc. (ASMB) stock

ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.50+1.21 (+5.68%)

Close on Nov 17, 2026Market cap $458.11MP/E –Yield –

Assembly Biosciences total assets

Total assets on the balance sheet at the end of each period.

Assembly Biosciences's total assets was $330.83M at Jun 30, 2026. For fiscal 2025 it was $257.59M, up 116.2% from the year before. Over ten years it grew 6.8% a year on average. The highest annual figure on record is $339.91M in fiscal 2019.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$257.59M+116.2%
FY2024Dec 31, 2024$119.17M-12.9%
FY2023Dec 31, 2023$136.82M+34.4%
FY2022Dec 31, 2022$101.79M-46.7%
FY2021Dec 31, 2021$191.06M-32.5%
FY2020Dec 31, 2020$283.25M-16.7%
FY2019Dec 31, 2019$339.91M+26.8%
FY2018Dec 31, 2018$268.05M+58.3%
FY2017Dec 31, 2017$169.30M+72.6%
FY2016Dec 31, 2016$98.12M-26.6%
FY2015Dec 31, 2015$133.74M+87.8%
FY2014Dec 31, 2014$71.23M+162.5%
FY2013Dec 31, 2013$27.13M+32.0%
FY2012Dec 31, 2012$20.56M-44.5%
FY2011Dec 31, 2011$37.05M+153.5%
FY2010Dec 31, 2010$14.62M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$330.83M+309.5%
Q1 FY2026Mar 31, 2026$235.51M+137.8%
Q4 FY2025Dec 31, 2025$257.59M+116.2%
Q3 FY2025Sep 30, 2025$240.00M+139.4%
Q2 FY2025Jun 30, 2025$80.78M-30.0%
Q1 FY2025Mar 31, 2025$99.02M-17.4%
Q4 FY2024Dec 31, 2024$119.17M-12.9%
Q3 FY2024Sep 30, 2024$100.26M+94.2%
Q2 FY2024Jun 30, 2024$115.32M+73.2%
Q1 FY2024Mar 31, 2024$119.88M+44.2%
Q4 FY2023Dec 31, 2023$136.82M+34.4%
Q3 FY2023Sep 30, 2023$51.63M-57.5%
Q2 FY2023Jun 30, 2023$66.58M-53.6%
Q1 FY2023Mar 31, 2023$83.12M-48.9%
Q4 FY2022Dec 31, 2022$101.79M-46.7%
Q3 FY2022Sep 30, 2022$121.52M-51.2%
Q2 FY2022Jun 30, 2022$143.45M-45.3%
Q1 FY2022Mar 31, 2022$162.73M-41.7%
Q4 FY2021Dec 31, 2021$191.06M-32.5%
Q3 FY2021Sep 30, 2021$248.97M-18.7%
Q2 FY2021Jun 30, 2021$262.14M-11.1%
Q1 FY2021Mar 31, 2021$278.90M-11.0%
Q4 FY2020Dec 31, 2020$283.25M-16.7%
Q3 FY2020Sep 30, 2020$306.31M+37.1%
Q2 FY2020Jun 30, 2020$294.80M+22.1%
Q1 FY2020Mar 31, 2020$313.31M+20.9%
Q4 FY2019Dec 31, 2019$339.91M+26.8%
Q3 FY2019Sep 30, 2019$223.35M-21.1%
Q2 FY2019Jun 30, 2019$241.51M+69.6%
Q1 FY2019Mar 31, 2019$259.25M+66.2%
Q4 FY2018Dec 31, 2018$268.05M+58.3%
Q3 FY2018Sep 30, 2018$282.98M+152.0%
Q2 FY2018Jun 30, 2018$142.42M+16.0%
Q1 FY2018Mar 31, 2018$156.02M+16.2%
Q4 FY2017Dec 31, 2017$169.30M+72.6%
Q3 FY2017Sep 30, 2017$112.31M+2.9%
Q2 FY2017Jun 30, 2017$122.77M–
Q1 FY2017Mar 31, 2017$134.28M–
Q4 FY2016Dec 31, 2016$98.12M–
Q3 FY2016Sep 30, 2016$109.13M–

More Assembly Biosciences figures

See a number that looks wrong?